Yu C - Search Results

1

Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/anti-PD-L1 therapeutic antibodies.

Wang L, Yu C, Yang Y, Gao K, Wang J. Wang L, et al. Among authors: yu c. J Pharm Biomed Anal. 2017 Oct 25;145:447-453. doi: 10.1016/j.jpba.2017.05.011. Epub 2017 May 8. J Pharm Biomed Anal. 2017. PMID: 28735186

2

TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis.

Wang L, Yu C, Lu Y, He P, Guo J, Zhang C, Song Q, Ma D, Shi T, Chen Y. Wang L, et al. Among authors: yu c. Apoptosis. 2007 Aug;12(8):1489-502. doi: 10.1007/s10495-007-0073-9. Apoptosis. 2007. PMID: 17492404

3

[Determination of drug antibody ratio in an antibody-drug conjugate].

Yu CF, Li M, Guo W, Wang L, Zhang F, Liu CY, Wang WB, Wang JZ, Gao K. Yu CF, et al. Yao Xue Xue Bao. 2014 Mar;49(3):363-7. Yao Xue Xue Bao. 2014. PMID: 24961108 Chinese.

4

[N terminal sequencing for practical detection of monoclonal antibody].

Guo W, Yu C, Li M, Wang L, Zhang F, Liu C, Wang W, Gao K. Guo W, et al. Among authors: yu c. Sheng Wu Gong Cheng Xue Bao. 2014 Sep;30(9):1473-80. Sheng Wu Gong Cheng Xue Bao. 2014. PMID: 25720162 Chinese.

5

[Development of a novel reporter gene method for determination of ADCC potency of anti-CD20 monoclonal antibody].

Liu CY, Wang L, Guo W, Yu CF, Zhang F, Wang WB, Li M, Gao K. Liu CY, et al. Yao Xue Xue Bao. 2015 Jan;50(1):94-8. Yao Xue Xue Bao. 2015. PMID: 25924482 Chinese.

6

At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody.

Yu C, Gao K, Zhu L, Wang W, Wang L, Zhang F, Liu C, Li M, Wormald MR, Rudd PM, Wang J. Yu C, et al. Sci Rep. 2016 Jan 29;7:20029. doi: 10.1038/srep20029. Sci Rep. 2016. PMID: 26823113 Free PMC article.

7

Development of a robust reporter-based assay for the bioactivity determination of anti-VEGF therapeutic antibodies.

Wang L, Xu GL, Gao K, Wilkinson J, Zhang F, Yu L, Liu CY, Yu CF, Wang WB, Li M, Chen W, Fan F, Cong M, Wang JZ. Wang L, et al. J Pharm Biomed Anal. 2016 Jun 5;125:212-8. doi: 10.1016/j.jpba.2016.03.042. Epub 2016 Mar 22. J Pharm Biomed Anal. 2016. PMID: 27042807

8

In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidate.

Chen L, Wang L, Shion H, Yu C, Yu YQ, Zhu L, Li M, Chen W, Gao K. Chen L, et al. Among authors: yu yq, yu c. MAbs. 2016 Oct;8(7):1210-1223. doi: 10.1080/19420862.2016.1204502. Epub 2016 Jul 5. MAbs. 2016. PMID: 27380163 Free PMC article.

9

Erratum: At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody.

Yu C, Gao K, Zhu L, Wang W, Wang L, Zhang F, Liu C, Li M, Wormald MR, Rudd PM, Wang J. Yu C, et al. Sci Rep. 2017 Jun 30;7:46385. doi: 10.1038/srep46385. Sci Rep. 2017. PMID: 28753200 Free PMC article.

10

Development of a robust reporter gene based assay for the bioactivity determination of IL-5-targeted therapeutic antibodies.

Fu Z, Yu C, Wang L, Gao K, Xu G, Wang W, Cao J, Wang J. Fu Z, et al. Among authors: yu c. J Pharm Biomed Anal. 2018 Jan 30;148:280-287. doi: 10.1016/j.jpba.2017.09.032. Epub 2017 Sep 28. J Pharm Biomed Anal. 2018. PMID: 29059618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,879 results

Search Page

Filters